MAYO CLINIC
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery
Phase 2
Completed
- Conditions
- Metastatic CancerSarcoma
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2011-05-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 39
- Registration Number
- NCT00652860
Radiation Therapy During and After Lumpectomy in Treating Women With Stage I or Stage II Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2008-03-31
- Last Posted Date
- 2018-03-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 80
- Registration Number
- NCT00647582
Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2008-03-28
- Last Posted Date
- 2011-05-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 47
- Registration Number
- NCT00645866
Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma
Not Applicable
Completed
- Conditions
- Sarcoma
- First Posted Date
- 2008-03-27
- Last Posted Date
- 2011-05-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT00645632
Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer
Not Applicable
Completed
- Conditions
- Non-melanomatous Skin Cancer
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2011-05-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 130
- Registration Number
- NCT00644384
Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer
Early Phase 1
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2018-10-31
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 45
- Registration Number
- NCT00640861
- Locations
- ๐บ๐ธ
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
๐บ๐ธMayo Clinic in Florida, Jacksonville, Florida, United States
๐บ๐ธMayo Clinic, Rochester, Minnesota, United States
Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- Interventions
- Biological: Anakinra (IL-1Ra)Drug: Dexamethasone acetate
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2018-06-07
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 55
- Registration Number
- NCT00635154
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma
Phase 2
Terminated
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- Interventions
- Biological: anti-thymocyte globulinDrug: melphalan
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 1
- Registration Number
- NCT00635024
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Effects of Cranberry Juice on Risk Factors for Cardiovascular Disease
Completed
- Conditions
- Atherosclerosis
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2011-08-12
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT00631306
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis
Phase 2
Terminated
- Conditions
- Chronic Myeloproliferative DisordersSecondary Myelofibrosis
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2015-12-30
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 4
- Registration Number
- NCT00630994
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath